Parametric Portfolio Associates’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$1.9M Sell
39,101
-4,434
-10% -$229K ﹤0.01% 2445
2021
Q4
$3.2M Buy
43,535
+6,756
+18% +$555K ﹤0.01% 2152
2021
Q3
$3.35M Buy
36,779
+24,663
+204% +$2.1M ﹤0.01% 2107
2021
Q2
$761K Buy
+12,116
New +$448K ﹤0.01% 2896

Other funds holding ASTH

Parametric Portfolio Associates's ASTH Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Astrana Health (ASTH) stake by 10% in Q1 2022, selling an estimated $229K and leaving 39,101 shares worth $1.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2445.

Parametric Portfolio Associates first reported a position in ASTH in Q2 2021 and has held it in 4 quarters since. The position peaked at $3.35M in Q3 2021. 139 funds tracked by Wall St. Rank hold ASTH as of Q1 2022.

  • Parametric Portfolio Associates held 39,101 shares of Astrana Health worth $1.9M as of Q1 2022.
  • Parametric Portfolio Associates sold 4,434 Astrana Health shares in Q1 2022, an estimated $229K.
  • Astrana Health made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2445 holding.
  • Parametric Portfolio Associates first reported a position in Astrana Health in Q2 2021 and has held it in 4 quarters since.
  • Parametric Portfolio Associates's Astrana Health position peaked at $3.35M in Q3 2021.
  • 139 funds tracked by Wall St. Rank held Astrana Health as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.